Showing results (361-370 of 454) with videos related to
Sort By:
Pageof 46
Cancer|May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinomaM E Juweid, G Hajjar, L C Swayne, et al.Cancer Research|November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodiesR D Blumenthal, R M Sharkey, L Haywood, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodiesT M Behr, R M Sharkey, M E Juweid, et al.Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.Nuclear Medicine Communications|September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodiesT M Behr, M E Juweid, R M Sharkey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabelsL B Shih, S R Thorpe, G L Griffiths, et al.The Journal of Rheumatology|December 1, 1983
Immunologic dynamics in cryapheresis for rheumatoid arthritisD J Wallace, E V Barnett, S Nichols, et al.Journal of Clinical Apheresis|January 14, 1999
Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritisD J Wallace, D Goldfinger, S H Pepkowitz, et al.Cancer|May 15, 1980
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoproteinD M Goldenberg, E E Kim, F Deland, et al.Cancer Research|December 1, 1995
Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragmentM J Blend, H Hyun, M Kozloff, et al.Pageof 46